SEC Form 4 · accession 0001171843-19-000438
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Paul Kowalsky
Officer — VP, Legal and Secretary
Period of report
Jan 18, 2019
Accepted (ET)
Jan 23, 2019 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.64 | Jan 18, 2019 | A | 60,000 | A | — | Jan 17, 2029 | Common Stock, $0.001 par value | 60,000 | 60,000 | D |
Explanation of responses
- F1The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments.